Hydrography-Driven Optical Domains in the Vaigat-Disko Bay and Godthabsfjord: Effects of Glacial Meltwater Discharge by Veloisa J. Mascarenhas, Oliver Zielinski, Oliver Zielinski

Get full text

Highly efficient and selective quantification of vanillin in food, beverages and pharmaceuticals using surfactant modified carbon paste sensor by Veera Erady, Ronald J. Mascarenhas, Ashis K. Satpati

Get full text

CARACTERIZAÇÃO FÍSICO-QUÍMICA E NUTRICIONAL DO FRUTO DA PALMA (Opuntia fícus indica L. Mill) CULTIVADA NO SERTÃO DO SUB-MÉDIO SÃO FRANCISCO. by Eudberg Alves Oliveira, S. F. Junqueira, R. J. Mascarenhas

Get full text

Catalytic Social Entrepreneurship to Combat Desperate Poverty: A Systems Approach by Oswald A. J. Mascarenhas, Ram Kesavan, Michael D. Bernacchi

Get full text

Catalytic Social Entrepreneurship to Combat Desperate Poverty: A Systems Approach by Oswald A. J. Mascarenhas, Ram Kesavan, Michael D. Bernacchi

Get full text

Graphene-based electrochemical immunosensors for early detection of oncomarker carcinoembryonic antigen by G. Manasa, Ronald J. Mascarenhas, Shweta J. Malode, Nagaraj P. Shetti

Get full text

Fundamentals of bio-electrochemical sensing by Mahesh M. Shanbhag, G. Manasa, Ronald J. Mascarenhas, Kunal Mondal, Nagaraj P. Shetti

Get full text

P1054: MYLOX-1: AN OPEN-LABEL, PHASE IIA STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR, GB2064, IN MYELOFIBROSIS by C. Harrison, J. Mascarenhas, R. Rampal, D. Cilloni, B. Lindmark, B. Singh, B. Jacoby, S. Verstovsek

Get full text

P1029: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PELABRESIB (CPI-0610) IN COMBINATION WITH RUXOLITINIB VS RUXOLITINIB OR FEDRATINIB MONOTHERAPY IN PATIENTS WITH INTERMEDIATE... by V. Gupta, J. Mascarenhas, M. Kremyanskaya, R. K. Rampal, M. Talpaz, J.-J. Kiladjian, A. Vannucchi, S. Verstovsek, G. Colak, D. Dey, C. Harrison

Get full text

P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE by J. Mascarenhas, A. T. Gerds, J. K. Kish, P. Abraham, A. Balanean, J. A. Nadal, D. Liassou, B. A. Feinberg, A. McBride, C. Harrison

Get full text

P1057: REAL-WORLD UTILIZATION OF FEDRATINIB FOR MYELOFIBROSIS FOLLOWING RUXOLITINIB FAILURE by C. Harrison, J. Mascarenhas, P. Abraham, J. A. Nadal, A. Balanean, A. McBride, J. K. Kish, D. Liassou, B. A. Feinberg, A. T. Gerds

Get full text

P1069: RETROSPECTIVE COMPARISON OF PATIENT OUTCOMES ON PACRITINIB VERSUS RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS AND THROMBOCYTOPENIA by C. Harrison, P. Bose, R. Mesa, A. Gerds, S. Oh, J.-J. Kiladjian, V. García-Gutierrez, A. Vannucchi, C. Scheid, M. Sobas, S. Verstovsek, S. Buckley, K. Roman-Torres, J. Mascarenhas

Get full text

P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS by J.-J. Kiladjian, A. Tefferi, F. Passamonti, A. Vannucchi, M. Talpaz, F. Cervantes, C. N. Harrison, R. A. Mesa, J. Mascarenhas, N. Schaap, S. Verstovsek, T. Devos, S. Rose, J. Zhang, O. Sy, A. Pardanani

Get full text

P1048: MYF3001: A RANDOMIZED OPEN LABEL, PHASE 3 STUDY TO EVALUATE IMETELSTAT VERSUS BEST AVAILABLE THERAPY IN PATIENTS WITH INTERMEDIATE-2 OR HIGH-RISK MYELOFIBROSIS REFRACTORY TO... by J. Mascarenhas, C. N. Harrison, J.-J. Kiladjian, R. S. Komrokji, S. Koschmieder, A. M. Vannucchi, T. Berry, D. Redding, L. Sherman, S. Dougherty, L. Peng, L. Sun, F. Huang, Y. Wan, F. M. Feller, A. Rizo, S. Verstovsek

Get full text

S198: BET INHIBITOR PELABRESIB (CPI-0610) COMBINED WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS — JAK INHIBITOR-NAÏVE OR WITH SUBOPTIMAL RESPONSE TO RUXOLITINIB — PRELIMINARY DA... by J. Mascarenhas, M. Kremyanskaya, A. Patriarca, C. Harrison, P. Bose, R. K. Rampal, F Palandri, T. Devos, F. Passamonti, G. Hobbs, M. Talpaz, A. Vannucchi, J.-J. Kiladjian, S. Verstovsek, R. Hoffman, M. E. Salama, D. Chen, P. Taverna, A. Chang, G. Colak, S. Klein, V. Gupta

Get full text

P1030: MANIFEST-2, A GLOBAL, PHASE 3, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROL STUDY OF PELABRESIB (CPI-0610) AND RUXOLITINIB VS PLACEBO AND RUXOLITINIB IN JAK INHIBITOR-NAÏVE MYEL... by C. Harrison, R. K. Rampal, V. Gupta, S. Verstovsek, M. Talpaz, J.-J. Kiladjian, R. Mesa, A. Kuykendall, A. Vannucchi, F. Palandri, S. Grosicki, T. Devos, E. Jourdan, M. J. Wondergem, H. K. Al-Ali, V. Buxhofer-Ausch, A. Alvarez-Larrán, S. Akhani, R. Muñoz-Carerras, Y. Sheykin, G. Colak, M. Harris, J. Mascarenhas

Get full text